24 May 2013
Keywords: novo, nordisk, dawn, study, reveals, resistance, insulin
Article | 08 September 2003
At the 18th International Diabetes Federation in Paris, Novo Nordisk presented findings from the DAWN (Diabetes Attitudes Wishes and Needs)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2003
23 May 2013
© 2013 thepharmaletter.com